Are noscapine and raloxifene ligands of the bradykinin B
B(2) receptor
Bradykinin
Human umbilical vein
Icatibant
Noscapine
Raloxifene
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
10
05
2022
revised:
15
06
2022
accepted:
16
06
2022
pubmed:
4
7
2022
medline:
18
8
2022
entrez:
3
7
2022
Statut:
ppublish
Résumé
The centrally acting antitussive opiate derivative, noscapine, has been claimed to be a non-competitive bradykinin B
Identifiants
pubmed: 35780642
pii: S1567-5769(22)00468-4
doi: 10.1016/j.intimp.2022.108984
pii:
doi:
Substances chimiques
Bradykinin Receptor Antagonists
0
Receptor, Bradykinin B1
0
Receptor, Bradykinin B2
0
Receptors, Bradykinin
0
Raloxifene Hydrochloride
4F86W47BR6
Noscapine
8V32U4AOQU
Bradykinin
S8TIM42R2W
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108984Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.